Regarding disease stages, AR positivity was similar between early (Stages I/II) and late-stage breast cancer (Stages III/IV), with 71.4% and 69.0%, respectively, expressing AR, suggesting that AR expression does not vary significantly with cancer stage (OR: 0.9, 95% CI: 0.3–2.5). Here, AR is linked to breast cancer.